Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Artes Biotechnology
Artes Biotechnology
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part I
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Effective ways to optimise heat exchangers
Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Media
Offering packet solutions for biopharmaceutical processes
Artes Biotechnology, and Minapharm Pharmaceuticals and Chemical Industries have made a business alliance to out-license their respective biopharmaceutical technologies
Research & Development
ARTES and BioSun announce codevelopment for HPV vaccine
ARTES Biotechnology and BioSun Pharmed are tojoin forces to develop and manufacture an HPV (human papilloma virus) vaccine in Iran
Research & Development
Artes Biotechnology and Burnet Institute join forces to develop novel hepatitis C vaccine
The project will combine Burnet's HepSeeVaxDelta3 technology with Artes’ Metavax technology
Research & Development
ARTES and Burnet join forces to develop anti-malaria vaccine
Transmission-blocking vaccines could play a significant role in the eventual eradication of malaria
Manufacturing
ARTES Biotechnology to collaborate with Bio Farma on vaccine development
First agreement for VLP-based vaccine technology transfer signed on 1 July in Bandung
Research & Development
Artes acquires Anavax VLP technology
Will develop processes for specific vaccines
Subscribe now